Crispr/cas-related methods and compositions for knocking out c5
US-2024415980-A1 · Dec 19, 2024 · US
Use of a new gene coding for a new member of the MCM2-8 family in pharmaceutical compositions
US9505828B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9505828-B2 |
| Application number | US-201313927944-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 26, 2013 |
| Priority date | May 13, 2005 |
| Publication date | Nov 29, 2016 |
| Grant date | Nov 29, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
An isolated antibody specifically binding the C-terminus part of the MCM9 protein, the C-terminus part of the MCM9 protein is one of the following sequences: the amino acids sequence from the position 391 to the position 1143 of the MCM9 proteins of the sequence as set forth in SEQ ID NO: 2 or 16, or the amino acids sequence from the position 391 to the position 1143 of the MCM9 protein of the sequence as set forth in SEQ ID NO: 8.
First claim
Opening claim text (preview).
The invention claimed is: 1. An isolated antibody specifically binding the C-terminus part of the MCM9 protein, said antibody being specifically directed against to the following peptide: PWRADNVESNKKKRLALDSE as set forth in SEQ ID NO: 66, said antibody being a monoclonal antibody.
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
- C07K16/18Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9505828B2 cover?
- An isolated antibody specifically binding the C-terminus part of the MCM9 protein, the C-terminus part of the MCM9 protein is one of the following sequences: the amino acids sequence from the position 391 to the position 1143 of the MCM9 proteins of the sequence as set forth in SEQ ID NO: 2 or 16, or the amino acids sequence from the position 391 to the position 1143 of the MCM9 protein of the …
- Who is the assignee on this patent?
- Centre Nat Rech Scient
- What technology area does this patent fall under?
- Primary CPC classification C07K16/18. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).